Frequent rhabdomyolysis in anti-NMDA receptor encephalitis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lim, Jung-Ah | - |
dc.contributor.author | Lee, Soon-Tae | - |
dc.contributor.author | Kim, Tae-Joon | - |
dc.contributor.author | Moon, Jangsup | - |
dc.contributor.author | Sunwoo, Jun-Sang | - |
dc.contributor.author | Byun, Jung-Ick | - |
dc.contributor.author | Jung, Keun-Hwa | - |
dc.contributor.author | Jung, Ki-Young | - |
dc.contributor.author | Chu, Kon | - |
dc.contributor.author | Lee, Sang Kun | - |
dc.date.accessioned | 2021-08-11T16:46:49Z | - |
dc.date.available | 2021-08-11T16:46:49Z | - |
dc.date.issued | 2016-09-15 | - |
dc.identifier.issn | 0165-5728 | - |
dc.identifier.issn | 1872-8421 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/8759 | - |
dc.description.abstract | The aim of this study was to analyze the clinical presentation and provocation factors of rhabdomyolysis in anti-NMDAR encephalitis. Among the 16 patients with anti-NMDAR encephalitis in our institutional cohort, nine patients had elevated CK enzyme levels and clinical evidence of rhabdomyolysis. Rhabdomyolysis was more frequent after immunotherapy. The use of dopamine receptor blocker (DRB) increased the risk of rhabdomyolysis. None of the patients without rhabdomyolysis received DRBs. Rhabdomyolysis is a frequent complication in anti-NMDAR encephalitis and more common after immunotherapy and the use of DRBs increases the risk. Therefore, DRBs should be administered carefully in patients with anti-NMDAR encephalitis. (C) 2016 Elsevier B.V. All rights reserved. | - |
dc.format.extent | 3 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Elsevier BV | - |
dc.title | Frequent rhabdomyolysis in anti-NMDA receptor encephalitis | - |
dc.type | Article | - |
dc.publisher.location | 네델란드 | - |
dc.identifier.doi | 10.1016/j.jneuroim.2016.08.002 | - |
dc.identifier.scopusid | 2-s2.0-84981313830 | - |
dc.identifier.wosid | 000383936600026 | - |
dc.identifier.bibliographicCitation | Journal of Neuroimmunology, v.298, pp 178 - 180 | - |
dc.citation.title | Journal of Neuroimmunology | - |
dc.citation.volume | 298 | - |
dc.citation.startPage | 178 | - |
dc.citation.endPage | 180 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Immunology | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalWebOfScienceCategory | Immunology | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.subject.keywordPlus | METHYL-D-ASPARTATE | - |
dc.subject.keywordPlus | DIAGNOSIS | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordAuthor | Encephalitis | - |
dc.subject.keywordAuthor | NMDA | - |
dc.subject.keywordAuthor | Autoimmune encephalitis | - |
dc.subject.keywordAuthor | Rhabdomyolysis | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.